Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP was delisted on the 13th of August, 2018.
54 hedge funds and large institutions have $37.3M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.
288% more call options, than puts
Call options by funds: $31K | Put options by funds: $8K
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
6% more funds holding
Funds holding: 51 → 54 (+3)
11% less capital invested
Capital invested by funds: $42.2M → $37.3M (-$4.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.17M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$852K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$756K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$570K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$429K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$1.78M |
| 2 |
Morgan Stanley
New York
|
-$1.34M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$756K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$287K |
| 5 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$232K |
JNP Hedge Fund Activity: Q4 2015 in Review
54 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) for Q4 2015, worth a combined $37.3M — down 11% from $42.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new JNP positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 13 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $1.17M. The largest seller was JW Asset Management, cutting an estimated $1.78M.
- 54 institutional investors held Juniper Pharmaceuticals, Inc. Common Stock (JNP) as of Q4 2015, up from 51 in Q3 2015.
- Funds reported $37.3M of Juniper Pharmaceuticals, Inc. Common Stock stock for Q4 2015, down 11% quarter-over-quarter.
- 10 funds opened new Juniper Pharmaceuticals, Inc. Common Stock positions in Q4 2015 and 7 closed out, a net change of +3 holders.
- The largest Juniper Pharmaceuticals, Inc. Common Stock buyer in Q4 2015 was Bridgeway Capital Management, an estimated $1.17M added.
- The largest Juniper Pharmaceuticals, Inc. Common Stock seller in Q4 2015 was JW Asset Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q4 2015.